AQR CAPITAL MANAGEMENT LLC – Regeneron Pharmaceuticals, Inc. Transaction History
AQR CAPITAL MANAGEMENT LLC portfolio value:
$296.42M
portfolio value
AQR CAPITAL MANAGEMENT LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -21.82% | -120.11K shares | -26.75M | $688.87 | 430.30K |
| Q2 2022 | share | Increase | +8.18% | 41.63K shares | -32.17M | $591.13 | 550.41K |
| Q1 2022 | share | Increase | +13.16% | 59.16K shares | 71.39M | $698.42 | 508.78K |
| Q4 2021 | share | Increase | +62.89% | 173.58K shares | 116.89M | $642.51 | 449.61K |
| Q3 2021 | share | Increase | +42.20% | 81.91K shares | 60.94M | $605.18 | 276.03K |
| Q2 2021 | share | Decrease | -33.22% | -96.54K shares | -31.41M | $558.54 | 194.11K |
| Q1 2021 | share | Decrease | -17.87% | -63.24K shares | -29.52M | $473.14 | 290.66K |
| Q4 2020 | share | Decrease | -23.91% | -111.19K shares | -93.31M | $483.11 | 353.90K |
| Q3 2020 | share | Increase | +28.54% | 103.28K shares | 37.54M | $559.78 | 465.10K |
| Q2 2020 | share | Decrease | -6.15% | -23.70K shares | 43.46M | $623.65 | 361.82K |
| Q1 2020 | share | Increase | +12.38% | 42.46K shares | 50.64M | $488.29 | 385.52K |
| Q4 2019 | share | Increase | +16.27% | 48.00K shares | 47.47M | $375.48 | 343.06K |
| Q3 2019 | share | Decrease | -15.92% | -55.84K shares | -28.59M | $277.4 | 295.05K |
| Q2 2019 | share | Decrease | -8.59% | -32.96K shares | -47.40M | $313 | 350.89K |
| Q1 2019 | share | Increase | +65.89% | 152.46K shares | 70.81M | $410.62 | 383.85K |
| Q4 2018 | share | Increase | +25.63% | 47.20K shares | 12.00M | $373.5 | 231.38K |
| Q3 2018 | share | Increase | +63.63% | 71.62K shares | 35.58M | $404.04 | 184.18K |
| Q2 2018 | share | Decrease | -61.36% | -178.74K shares | -61.48M | $344.99 | 112.55K |
| Q1 2018 | share | Increase | +211.06% | 197.65K shares | 65.10M | $344.36 | 291.29K |
| Q4 2017 | share | Increase | +94.29% | 45.44K shares | 13.65M | $375.96 | 93.64K |
| Q3 2017 | share | Increase | +757.06% | 42.57K shares | 18.79M | $447.12 | 48.20K |
| Q2 2017 | share | Decrease | -36.13% | -3.18K shares | -650K | $491.14 | 5.62K |
| Q1 2017 | share | Increase | +201.44% | 5.88K shares | 2.34M | $387.51 | 8.80K |
| Q4 2016 | share | Decrease | -15.38% | -531 shares | -316K | $367.09 | 2.92K |
| Q3 2016 | share | Increase | +51.07% | 1.16K shares | 590K | $402.02 | 3.45K |
| Q2 2016 | share | Decrease | -79.40% | -8.80K shares | -3.2M | $349.23 | 2.28K |
| Q1 2016 | share | Decrease | -75.54% | -34.25K shares | -20.62M | $360.44 | 11.09K |